Cogent Biosciences Files 8-K with Corporate Updates
Ticker: COGT · Form: 8-K · Filed: Jun 5, 2025 · CIK: 1622229
| Field | Detail |
|---|---|
| Company | Cogent Biosciences, INC. (COGT) |
| Form Type | 8-K |
| Filed Date | Jun 5, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, disclosure, filing
TL;DR
Cogent Biosciences filed an 8-K on June 5th detailing corporate changes and disclosures from June 4th.
AI Summary
Cogent Biosciences, Inc. filed an 8-K on June 5, 2025, reporting on events that occurred on June 4, 2025. The filing indicates amendments to articles of incorporation or bylaws, submission of matters to a vote of security holders, Regulation FD disclosures, and financial statements/exhibits. The company was formerly known as Unum Therapeutics Inc. and Unum Therapeutics, Inc.
Why It Matters
This 8-K filing signals important corporate governance and disclosure events for Cogent Biosciences, potentially impacting investor understanding of the company's structure and recent activities.
Risk Assessment
Risk Level: low — This filing is a routine corporate disclosure and does not appear to contain significant new risks or material adverse information.
Key Players & Entities
- Cogent Biosciences, Inc. (company) — Registrant
- Unum Therapeutics Inc. (company) — Former company name
- Unum Therapeutics, Inc. (company) — Former company name
- June 4, 2025 (date) — Date of earliest event reported
- June 5, 2025 (date) — Date of report
FAQ
What specific amendments were made to Cogent Biosciences' articles of incorporation or bylaws?
The filing indicates that amendments were made, but the specific details of these amendments are not provided in the provided text excerpt.
What matters were submitted to a vote of security holders?
The filing states that matters were submitted to a vote of security holders, but the nature of these matters is not detailed in the provided excerpt.
What is the subject of the Regulation FD disclosure?
The filing mentions a Regulation FD disclosure, but the content of this disclosure is not specified in the provided text.
When did Cogent Biosciences change its name from Unum Therapeutics Inc.?
Cogent Biosciences changed its name from Unum Therapeutics Inc. on April 2, 2018.
What is the fiscal year end for Cogent Biosciences?
The fiscal year end for Cogent Biosciences is December 31.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 5, 2025 regarding Cogent Biosciences, Inc. (COGT).